Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Regeneron

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Regeneron's Japan sales performance.

regeneron

Novartis bags US okay for Lucentis follow-up Beovu in wet AMD

Novartis bags US okay for Lucentis follow-up Beovu in wet AMD

Novartis’ drug was the first VEGF inhibitor to reach the market for wet AMD but is facing the triple challenge of Bayer/Regeneron’s rival drug  Eylea (aflibercept) – now the market ... Roche sells Lucentis in the US and made $1.7bn from the

Pfizer pays $250m upfront to Akcea for phase 2 antisense drug

Pfizer pays $250m upfront to Akcea for phase 2 antisense drug drugs. New therapies like Novartis’ heart failure therapy Entresto (sacubitril/valsartan) and cholesterol-lowering PCSK9 inhibitors from Amgen and Sanofi/Regeneron have re-injected growth into the market, although they have

TMC preps filings for inclisiran after final phase 3 trials hit the mark

TMC preps filings for inclisiran after final phase 3 trials hit the mark If approved, inclisiran will compete most closely with two antibody-based PCSK9 inhibitors – Amgen’s Repatha (evolocumab) and Sanofi/Regeneron’s Praluent (alirocumab) – but will offer efficacy that is at least ... Repatha brought in $152m in the

TMC’s full data for inclisiran impresses at ESC

TMC’s full data for inclisiran impresses at ESC Other PCKS9 targeting drugs, including Amgen’s  Repatha and Sanofi/Regeneron’s  Praluent, directly target the  PCKS9 protein.

US court backs Sanofi/Regeneron in PCSK9 patent dispute with Amgen

US court backs Sanofi/Regeneron in PCSK9 patent dispute with Amgen Latest point in tit-for-tat battle between rivals. A US district court has handed a win to Sanofi and Regeneron in their five-year-old patent dispute with Amgen over ... Amgen filed a patent infringement complaint against Sanofi/Regeneron in 2014,

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics